FindTrial
Sign In

An open-label, randomized, active-controlled study in patients with community-acquired pneumonia.

An open-label, randomized, active-controlled study in patients with community-acquired pneumonia.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220476
Enrollment
Unknown
Registered
2007-12-05
Start date
2007-12-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired pneumonia

Interventions

investigational material(s) Generic name etc : DR-3355inj INN of investigational material : Therapeutic category code : 624 Synthetic antibacterials Dosage and Administration for Investigational mate

Sponsors

DAIICHISANKYO Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient with community-acquired pneumonia who requires hospitalization, aged 20 to 79 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026